About Us
SARAH CANNON RESEARCH UK NOW ENROLLING PATIENTS ON CLINICAL TRIALS
SCRI’s first Phase I cancer trial program outside of U.S.
Sarah Cannon Research UK (SCRUK), an affiliate of the Sarah Cannon Research Institute, in partnership with Leaders in Oncology Care and HCA International, has opened a cancer drug development program in the heart of London. With a focus on Phase I trials, SCRUK is Sarah Cannon Research Institute's first research program for clinical trials outside the United States.